A Long-Term Safety Follow-up Registry for Patients Who Received Treatment With Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
Clinical trial NCT07700966 · RECRUITING
Trial details
- NCT number
- NCT07700966
- Sponsor
- Abeona Therapeutics, Inc
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-25
- Primary completion
- 2045-04-01
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.